Ophthalmology

Episodes 1-14 of 14

• • 

    

    Michael S. Ip, MD

    Peer

  • 

    

    Christina Y. Weng, MD, MBA

    Peer

  2

  

  RestartResume

  Time Is Vision: Early Recognition and Management of Neovascular AMD and RVO

  RestartResume

  Time Is Vision: Early Recognition and Management of Neovascular AMD and RVO

  0.25 credits

  Time Is Vision: Early Recognition and Management of Neovascular AMD and RVO

  0.25 credits

• • 

    

    Emily Chew, MD

    Peer

  • 

    

    Neil Bressler, MD

    Peer

  • 

    

    Joseph M. Coney, MD

    Peer

  • 

    

    Steven Ferrucci, OD, FAAO

    Peer

  2

  

  RestartResume

  nAMD and RVO: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral

  RestartResume

  nAMD and RVO: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral

  0.25 credits

  nAMD and RVO: Understanding the Impact on Patient Lives and the Need for Time...

  0.25 credits

• • 

    

    Adrienne W. Scott, MD

    Peer

  • 

    

    Peter A. Campochiaro, MD

    Peer

  • 

    

    Rahul N. Khurana, MD

    Peer

  2

  

  RestartResume

  Seeing Eye to Eye: Case Series on Treatment Strategies for RVO

  RestartResume

  Seeing Eye to Eye: Case Series on Treatment Strategies for RVO

  0.25 credits

  Seeing Eye to Eye: Case Series on Treatment Strategies for RVO

  0.25 credits

• • 

    

    Diana V. Do, MD

    Peer

  • 

    

    Julia Haller, MD

    Peer

  • 

    

    Rishi P. Singh, MD

    Peer

  1

  

  RestartResume

  Optimizing Vision Outcomes in nAMD

  RestartResume

  Optimizing Vision Outcomes in nAMD

  0.25 credits

  Optimizing Vision Outcomes in nAMD

  0.25 credits

• • 

    

    Peter K. Kaiser, MD

    Peer

  • 

    

    Dante J. Pieramici, MD

    Peer

  2

  

  RestartResume

  Neovascular AMD and RVO: Distinguishing the Differential

  RestartResume

  Neovascular AMD and RVO: Distinguishing the Differential

  0.25 credits

  Neovascular AMD and RVO: Distinguishing the Differential

  0.25 credits

• • 

    

    Charles Wykoff, MD, PhD

    Peer

  1

  

  RestartResume

  Seeing Eye to Eye: Case Series on Treatment Strategies for Neovascular AMD

  RestartResume

  Seeing Eye to Eye: Case Series on Treatment Strategies for Neovascular AMD

  0.25 credits

  Seeing Eye to Eye: Case Series on Treatment Strategies for Neovascular AMD

  0.25 credits

• • 

    

    Neil Bressler, MD

    Peer

  0

  

  RestartResume

  Take Control of Wet AMD

  RestartResume

  Take Control of Wet AMD

  Take Control of Wet AMD

• • 

    

    Diana Shechtman, OD, FAAO

    Peer

  • 

    

    Mark T. Dunbar, OD, FAAO

    Peer

  2

  

  RestartResume

  Time Is Vision: The Critical Role of Early Diagnosis and Referral in Neovascular AMD and RVO

  RestartResume

  Time Is Vision: The Critical Role of Early Diagnosis and Referral in Neovascular AMD and RVO

  0.25 credits

  Time Is Vision: The Critical Role of Early Diagnosis and Referral in Neovascu...

  0.25 credits

• • 

    

    Julia Haller, MD

    Peer

  3

  

  RestartResume

  Time Is Vision: Improving Your Diagnostic Skills

  RestartResume

  Time Is Vision: Improving Your Diagnostic Skills

  0.25 credits

  Time Is Vision: Improving Your Diagnostic Skills

  0.25 credits

• • 

    

    Rishi P. Singh, MD

    Peer

  • 

    

    Sophie J. Bakri, MD

    Peer

  • 

    

    Dilsher S. Dhoot, MD

    Peer

  • 

    

    David Eichenbaum, MD

    Peer

  9

  

  RestartResume

  Managing COVID-19 Related Delays In Patients with Neovascular AMD

  RestartResume

  Managing COVID-19 Related Delays In Patients with Neovascular AMD

  1.00 credits

  Managing COVID-19 Related Delays In Patients with Neovascular AMD

  1.00 credits

• • 

    

    David M. Brown, MD, FACS

    Peer

  • 

    

    Rishi P. Singh, MD

    Peer

  7

  

  RestartResume

  Viewpoints on Managing DR: Addressing Moderate-to-Severe NPDR

  RestartResume

  Viewpoints on Managing DR: Addressing Moderate-to-Severe NPDR

  0.25 credits

  Viewpoints on Managing DR: Addressing Moderate-to-Severe NPDR

  0.25 credits

• • 

    

    Mark Dunbar, OD, FAAO

    Peer

  • 

    

    Jay M. Haynie, OD, FAAO

    Peer

  10

  

  RestartResume

  Viewpoints on Cases in Diabetic Retinopathy: What the Optometrist Needs to Know

  RestartResume

  Viewpoints on Cases in Diabetic Retinopathy: What the Optometrist Needs to Know

  0.25 credits

  Viewpoints on Cases in Diabetic Retinopathy: What the Optometrist Needs to Know

  0.25 credits

• • 

    

    David S. Friedman, MD, PhD, MPH

    Peer

  • 

    

    Steven J. Gedde, MD

    Peer

  • 

    

    W. Daniel Stamer, PhD

    Peer

  13

  

  RestartResume

  Mechanisms of Pressure Relief in Glaucoma: Pharmacologic & Surgical Advances for Refractory POAG or Non-Adherence

  RestartResume

  Mechanisms of Pressure Relief in Glaucoma: Pharmacologic & Surgical Advances for Refractory POAG or Non-Adherence

  Mechanisms of Pressure Relief in Glaucoma: Pharmacologic & Surgical Advances ...

• • 

    

    Shira Johnson, MD

    Peer

  • 

    

    Jean Bennett, MD, PhD

    Peer

  20

  

  RestartResume

  Curing Blindness: How Researchers are Utilizing Gene Therapy

  RestartResume

  Curing Blindness: How Researchers are Utilizing Gene Therapy

  Curing Blindness: How Researchers are Utilizing Gene Therapy